Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> A >> (3aS,4S,6aR)-N-[6-[[3-[[O-(N-Acetyl-alpha-neuraminosyl)-(2→3)-O-beta-D-galactopyranosyl-(1→4)-beta-D-glucopyranosyl]oxy]propyl]amino]-6-oxohexyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide

(3aS,4S,6aR)-N-[6-[[3-[[O-(N-Acetyl-alpha-neuraminosyl)-(2→3)-O-beta-D-galactopyranosyl-(1→4)-beta-D-glucopyranosyl]oxy]propyl]amino]-6-oxohexyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide
[CAS# 1384441-58-0]

List of Suppliers
Carbosynth China Ltd. China Inquire  
+86 (512) 6260-5585
sales@carbosynth.com
QQ chat
Chemical manufacturer since 2006
chemBlink standard supplier since 2016
Complete supplier list of (3aS,4S,6aR)-N-[6-[[3-[[O-(N-Acetyl-alpha-neuraminosyl)-(2→3)-O-beta-D-galactopyranosyl-(1→4)-beta-D-glucopyranosyl]oxy]propyl]amino]-6-oxohexyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide
Identification
Classification Organic raw materials >> Heterocyclic compound >> Imidazoles
Name (3aS,4S,6aR)-N-[6-[[3-[[O-(N-Acetyl-alpha-neuraminosyl)-(2→3)-O-beta-D-galactopyranosyl-(1→4)-beta-D-glucopyranosyl]oxy]propyl]amino]-6-oxohexyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide
Molecular Structure CAS # 1384441-58-0, (3aS,4S,6aR)-N-[6-[[3-[[O-(N-Acetyl-alpha-neuraminosyl)-(2→3)-O-beta-D-galactopyranosyl-(1→4)-beta-D-glucopyranosyl]oxy]propyl]amino]-6-oxohexyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide
Molecular Formula C42H71N5O22S
Molecular Weight 1030.10
CAS Registry Number 1384441-58-0
Properties
Solubility Very slightly soluble (0.2 g/L) (25 ºC), Calc.*
Density 1.54±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2016 ACD/Labs)
Market Analysis Reports
List of Reports Available for (3aS,4S,6aR)-N-[6-[[3-[[O-(N-Acetyl-alpha-neuraminosyl)-(2→3)-O-beta-D-galactopyranosyl-(1→4)-beta-D-glucopyranosyl]oxy]propyl]amino]-6-oxohexyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide
Related Products
(3beta)-3-(Acetyloxy)-17-(1H-benzimidazol-1-yl)androsta-5,16-diene-16-carboxaldehyde  2-(Acetyloxy)benzoic acid mix with 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine 2-Hydroxy-1,2,3-propanetricarboxylate  2-(Acetyloxy)benzoic acid polymer with 2-hydroxybenzoic acid  (4R,5S,6S)-5-(Acetyloxy)-4-(benzoyloxy)-6-[(benzoyloxy)methyl]-6-hydroxy-2-cyclohexen-1-one  [2aR-(2aalpha,4beta,4abeta,6beta,9alpha,11alpha,12alpha,12aalpha,12balpha)]-12b-(Acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-4,9,11-trihydroxy-6-methoxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one  2'-(Acetyloxy)-[1,1'-biphenyl]-2-carboxylic acid 4-(acetylamino)phenyl ester  (2R)-2-(Acetyloxy)-N-[(1S,2S,3R)-2,3-bis(acetyloxy)-1-[(acetyloxy)methyl]heptadecyl]tetracosanamide  2-(Acetyloxy)-N,N-bis[2-(acetyloxy)ethyl]propanamide  (7alpha,17beta)-17-(Acetyloxy)-7-(9-bromononyl)estr-4-en-3-one  (3aS,4S,6aR)-N-[6-[[3-[[O-(N-Acetyl-alpha-neuraminosyl)-(2→6)-O-beta-D-galactopyranosyl-(1→4)-beta-D-glucopyranosyl]oxy]propyl]amino]-6-oxohexyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide  O-(N-Acetyl-alpha-neuraminosyl)-(2→3)-O-beta-D-galactopyranosyl-(1→4)-D-glucose monosodium salt  O-(N-Acetyl-alpha-neuraminosyl)-[2→3(or 2→6)]-O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)-O-alpha-D-mannopyranosyl-(1→6)-O-[O-(N-acetyl-alpha-neuraminosyl)-[2→3(or 2→6)]-O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)-O-[O-(N-acetyl-alpha-neuraminosyl)-[2→3(or 2→6)]-O-beta-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)]-alpha-D-mannopyranosyl-(1→3)]-O-beta-D-mannopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-O-(N-acetyl-alpha-neuraminosyl)-[2→3(or 2→6)]-O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)-O-alpha-D-mannopyranosyl-(1→6)-O-[O-(N-acetyl-alpha-neuraminosyl)-[2→3(or 2→6)]-O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)-O-[O-(N-acetyl-alpha-neuraminosyl)-[2→3(or 2→6)]-O-beta-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)]-alpha-D-mannopyranosyl-(1→3)]-O-beta-D-mannopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-D-glucose  O-(N-Acetyl-alpha-neuraminosyl)-[2→3(or 2→6)]-O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)-O-alpha-D-mannopyranosyl-(1→3)-O-[O-(N-acetyl-alpha-neuraminosyl)-[2→3(or 2→6)]-O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)-alpha-D-mannopyranosyl-(1→6)]-O-beta-D-mannopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)-O-[6-deoxy-alpha-L-galactopyranosyl-(1→6)]-2-(acetylamino)-2-deoxy-D-glucose  O-(N-Acetyl-alpha-neuraminosyl)-[2→3(or 2→6)]-O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)-O-alpha-D-mannopyranosyl-[1→3(or 1→6)]-O-[O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)-alpha-D-mannopyranosyl-[1→6(or 1→3)]]-O-beta-D-mannopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-D-glucose  2-Acetyl-5-nitrobenzo[b]furan  3-Acetyl-5-nitrobenzoic acid  2-Acetyl-7-nitrofluorene  1-Acetyl-5-nitroindoline  2-Acetyl-4-nitro-1H-isoindole-1,3(2H)-dione  N-Acetyl-2-O-(4-nitrophenyl)-alpha-neuraminic acid monoammonium salt